{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:00:35Z","timestamp":1794632435716,"version":"4.9.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2024.126699","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:32:43Z","timestamp":1738218763000},"page":"126699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Vaccine microarray patch self-administration: A preliminary study in adults 50\u00a0years of age and over"],"prefix":"10.1016","volume":"48","author":[{"given":"C.","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mowbray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.G.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Booy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Mortimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Siller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126699_bb0005","doi-asserted-by":"crossref","first-page":"2189409","DOI":"10.1080\/21645515.2023.2189409","article-title":"Evaluation of the self-administration potential of high-density microarray patches to human skin: a preliminary study","volume":"19","author":"Baker","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126699_bb0010","doi-asserted-by":"crossref","first-page":"2018863","DOI":"10.1080\/21645515.2021.2018863","article-title":"Usability, acceptability, and feasibility of a high-density microarray patch (HD-MAP) applicator as a delivery method for vaccination in clinical settings","volume":"18","author":"Davies","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"41","key":"10.1016\/j.vaccine.2024.126699_bb0015","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2023.08.027","article-title":"Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates","volume":"41","author":"Hacker","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0020","series-title":"Estimating the economic and public health impact of microarray patch (MAP)-administered vaccines in pandemics","author":"Becker","year":"2022"},{"key":"10.1016\/j.vaccine.2024.126699_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012247","article-title":"Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysis","volume":"8","author":"Berger","year":"2023","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2024.126699_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"Rouphael","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126699_bb0035","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.vaccine.2014.01.076","article-title":"Microneedle patches: usability and acceptability for self-vaccination against influenza","volume":"32","author":"Norman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0040","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1016\/j.vaccine.2017.10.021","article-title":"Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects","volume":"35","author":"Griffin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0045","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(24)00532-4","article-title":"A measles and rubella vaccine microneedle patch in the Gambia: a phase 1\/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial","volume":"403","author":"Adigweme","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126699_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003024","article-title":"Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: results from a randomized, controlled phase I clinical trial","volume":"17","author":"Forster","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2024.126699_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303450","article-title":"Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults","volume":"19","author":"Garg","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126699_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.02.040","article-title":"Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects","volume":"128","author":"Arya","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2024.126699_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255282","article-title":"Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial","volume":"16","author":"Depelsenaire","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126699_bb0070","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1016\/j.vaccine.2017.07.083","article-title":"Acceptability of microneedle-patch vaccines: a qualitative analysis of the opinions of parents","volume":"35","author":"Marshall","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0075","first-page":"10","article-title":"Local response and barrier recovery in elderly skin following the application of high-density microarray patches","author":"Iredahl","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126699_bb0080","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.vaccine.2015.02.076","article-title":"An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine","volume":"33","author":"Lee","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0085","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1016\/j.vaccine.2021.08.016","article-title":"Micro array patch (MAP) for the delivery of thermostable vaccines in Australia: a cost\/benefit analysis","volume":"39","author":"Bozorgi","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2105\/AJPH.94.3.361","article-title":"Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement","volume":"94","author":"Des Jarlais D, Lyles C, Crepaz N, Trend Group","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2024.126699_bb0095","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","article-title":"A consensus-based checklist for reporting of survey studies (CROSS)","volume":"36","author":"Sharma","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2024.126699_bb0100","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.vaccine.2018.02.079","article-title":"Human papillomavirus vaccine acceptability and decision-making among adolescent boys and parents: a meta-ethnography of qualitative studies","volume":"36","author":"Lacombe-Duncan","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-publhealth-031210-101141","article-title":"Ecological models revisited: their uses and evolution in health promotion over two decades","volume":"32","author":"Lucie","year":"2011","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.vaccine.2024.126699_bb0110","series-title":"Health behavior: Theory research and practice","first-page":"95","article-title":"Theory of reasoned action, theory of planned behaviour, and the integrated behavioural model","author":"Montano","year":"2014"},{"key":"10.1016\/j.vaccine.2024.126699_bb0115","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/smll.201000331","article-title":"Nanopatch-targeted skin vaccination against West Nile virus and chikungunya virus in mice","volume":"6","author":"Prow","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.vaccine.2024.126699_bb0120","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.vaccine.2018.05.053","article-title":"Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch\u2122)","volume":"36","author":"Fernando","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","article-title":"ImageJ2: ImageJ for the next generation of scientific image data","volume":"18","author":"Rueden","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2024.126699_bb0130","doi-asserted-by":"crossref","first-page":"18468","DOI":"10.1038\/s41598-020-75169-4","article-title":"Innate local response and tissue recovery following application of high density microarray patches to human skin","volume":"10","author":"Muller","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126699_bb0135","doi-asserted-by":"crossref","first-page":"2018863","DOI":"10.1080\/21645515.2021.2018863","article-title":"Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settings","volume":"18","author":"Davies","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126699_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.vaccine.2024.126699_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(21)00192-4","article-title":"Comparison of the safety and immunogenicity of a novel matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial","volume":"22","author":"Shinde","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126699_bb0150","article-title":"Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study","volume":"40","author":"Liu","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2024.126699_bb0155","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/s12879-022-07814-4","article-title":"High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of omicron","volume":"22","author":"Baum","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126699_bb0160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2023.07.001","article-title":"Assessing the risk of a clinically significant infection from a microneedle Array patch (MAP) product","volume":"361","author":"Dul","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.126699_bb0165","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.amjmed.2007.10.040","article-title":"Complications of viral influenza","volume":"121","author":"Rothberg","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2024.126699_bb0170","doi-asserted-by":"crossref","first-page":"2271304","DOI":"10.1080\/21645515.2023.2271304","article-title":"Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities","volume":"19","author":"Moa","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126699_bb0175","article-title":"Skin Immunosenescence and type 2 inflammation: a Mini-review with an Inflammaging perspective","volume":"10","author":"Chen","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2024.126699_bb0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vaccine.2016.11.013","article-title":"Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis","volume":"35","author":"Young","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0185","first-page":"14","article-title":"Enhancing immunogenicity of influenza vaccine in the elderly through intradermal vaccination: a literature analysis","author":"Quach","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126699_bb0190","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2013.09.074","article-title":"Immunogenicity and safety of Fluzone((R)) intradermal and high-dose influenza vaccines in older adults >\/=65 years of age: a randomized, controlled, phase II trial","volume":"32","author":"Tsang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0195","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1016\/j.vaccine.2016.09.008","article-title":"A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly","volume":"34","author":"Levin","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jech.2003.018044","article-title":"Ecological perspectives in health research","volume":"59","author":"McLaren","year":"2005","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2024.126699_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.puhe.2017.12.007","article-title":"Factors influencing seasonal influenza vaccination behaviour among elderly people: a systematic review","volume":"156","author":"Kan","year":"2018","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2024.126699_bb0210","article-title":"Age as a moderator of health outcomes and Trust in Physicians","volume":"8982643231187104","author":"Katz","year":"2023","journal-title":"J Aging Health"},{"key":"10.1016\/j.vaccine.2024.126699_bb0215","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.3399\/bjgp14X682297","article-title":"Older patients and their GPs: shared decision making in enhancing trust","volume":"64","author":"Butterworth","year":"2014","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.vaccine.2024.126699_bb0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1529100618760521","article-title":"Increasing vaccination: putting psychological science into action","volume":"18","author":"Brewer","year":"2017","journal-title":"Psychol Sci Public Interest"},{"key":"10.1016\/j.vaccine.2024.126699_bb0225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/vaccines9070713","article-title":"Healthcare Providers\u2019 vaccine perceptions, hesitancy, and recommendation to patients: a systematic review","volume":"9","author":"Lin","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126699_bb0230","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.vaccine.2019.02.079","article-title":"End-user acceptability study of the nanopatch; a microarray patch (MAP) for child immunization in low and middle-income countries","volume":"37","author":"Guillermet","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126699_bb0235","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1016\/j.vaccine.2015.06.061","article-title":"Self-administration of intranasal influenza vaccine: immunogenicity and volunteer acceptance","volume":"33","author":"Burgess","year":"2015","journal-title":"Vaccine"},{"issue":"204\u201311","key":"10.1016\/j.vaccine.2024.126699_bb0240","article-title":"A feasibility trial of home Administration of Intranasal Vaccine by parents to eligible children","volume":"39","author":"Jhaveri","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2024.126699_bb0245","first-page":"1945","article-title":"FDA will evaluate first self-administered FluMist vaccine","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.126699_bb0250","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the expanded Programme on immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126699_bb0255","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1073\/pnas.1704507114","article-title":"Simply put: vaccination saves lives","volume":"114","author":"Orenstein","year":"2017","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:01:01Z","timestamp":1743876061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24013811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":51,"alternative-id":["S0264410X24013811"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126699","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine microarray patch self-administration: A preliminary study in adults 50\u00a0years of age and over","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126699"}}